Please login to the form below

Not currently logged in
Email:
Password:

compulsory licence

This page shows the latest compulsory licence news and features for those working in and with pharma, biotech and healthcare.

UK patient activist group takes aim at Orkambi patent

UK patient activist group takes aim at Orkambi patent

Crown use is a little-known provision in UK law which allows the government to bypass patents and issue a compulsory licence on a medicine if there is deemed to be ... The push for compulsory licensing has been driven by a newly-formed patient activist

Latest news

  • Bayer fails to overturn Nexavar compulsory licence in India Bayer fails to overturn Nexavar compulsory licence in India

    Natco Pharma allowed to sell cut-price version of cancer drug. Bayer's first attempt at overturning a compulsory license in India for its cancer drug Nexavar was knocked back yesterday ... Natco received the the compulsory licence in March 2012 on the

  • India's patents versus India's patients India's patents versus India's patients

    Alternatively, we might see more examples of compulsory licensing in India where a government allows a third party to produce a patented product without the consent of the patent owner. . ... In a landmark decision earlier this year, India granted its

  • India could hit Roche and BMS with compulsory licences India could hit Roche and BMS with compulsory licences

    According to local newspaper reports, the Department of Pharmaceuticals is considering introducing 'compulsory licences' for Roche's breast cancer treatment Herceptin (trastuzumab), as well as Bristol-Myers Squibb's leukaemia medicine ... The first

  • Navigating the minefield

    The use of a compulsory licence is only allowed if efforts to obtain a voluntary licence on reasonable terms and conditions are made first. ... This has already happened in recent years. For instance, in November 2007, Thailand issued a compulsory

  • Emerging market: Brazil

    Once a nation with scant regard for patent rights (in 2007 the government issued a compulsory licence under World Trade Organization rules effectively to void the patent on Merck's HIV

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • Intellectual property threats in the BRIC markets Intellectual property threats in the BRIC markets

    Brazil, for example, used the threat of compulsory licensing to obtain discounts for various HIV drugs, before actually issuing a compulsory licence in 2007 for Stocrin. ... of the compulsory licence process for Herceptin, Sprycel and Ixempra,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics